Leonard Kaps

Johannes Gutenberg University Mainz — Germany

Medicine · Health Sciences

23h-index1.7kcitations147works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(48), Liver Disease and Transplantation(40), RNA Interference and Gene Delivery(24), Liver physiology and pathology(16), Nanoparticle-Based Drug Delivery(14)

Publications147 total

Biodegradable Carbonate Nanogels Loaded with Anti MFAP‐5 siRNA for Anti‐stromal Therapy of Hepatocellular Carcinoma
Advanced Science·2026Open Access
Inflammatory Bowel Diseases Are Not Associated with an Increased Risk of Autoimmune Thyroiditis
Medical Sciences·2026Open Access
P1054 TNF-α Therapy Does Not Alter Periodontal Staging in Patients With IBD
Journal of Crohn s and Colitis·2026
Inflammatory bowel diseases are associated with an increased risk of liver cirrhosis in a population-based study
Zeitschrift für Gastroenterologie·2026
Unfolding and Degradation of Micellar Immunodrug Carriers Derived From End Group Modified Aliphatic Poly(Carbonate)s with Acid‐Responsive Ketal Side Groups
Advanced Materials·2025Open Access
Collagen turnover biomarkers to predict outcome of patients with gastric cancer
Zeitschrift für Gastroenterologie·2025
Hepatic Inflammation and Liver Injury in a Model of Bacterial Infection Triggered Acute‐on‐Chronic Liver Injury
Journal of Gastroenterology and Hepatology·2025· 1 citedOpen Access
FRI-145 miR148a-3p may play a direct role in regulating inflammatory responses in bacterial infection related acute-on-chronic liver injury
Journal of Hepatology·2025
SAT-090 MFAP-5 siRNA nanohydrogels for antiangiogenic stromaltargeting HCC therapy
Journal of Hepatology·2025
SAT-089-YI mRNA-based vaccination for tumor neoantigens to induce a therapeutic T cell response in HCC
Journal of Hepatology·2025
mRNA-LNP vaccine strategies: Effects of adjuvants on non-parenchymal liver cells and tolerance
Molecular Therapy — Methods & Clinical Development·2025· 4 citedOpen Access
Collagen turnover biomarkers to predict outcome of patients with biliary cancer
BMC Gastroenterology·2025· 1 citedOpen Access
Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle Formulations
Cancers·2025· 7 citedOpen Access
A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing
Pharmacological Research·2024· 3 citedOpen Access
QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosis
JHEP Reports·2024· 1 citedOpen Access
Blocking interleukin-1 receptor type 1 (IL-1R1) signaling in hepatocytes slows down diethylnitrosamine-induced liver tumor growth in obese mice
Hepatology Communications·2024· 6 citedOpen Access
Collagen turnover biomarkers to predict outcome of patients with biliary cancer
2024Open Access
Multicompartment Polyion Complex Micelles Based on Triblock Polypept(o)ides Mediate Efficient siRNA Delivery to Cancer‐Associated Fibroblasts for Antistromal Therapy of Hepatocellular Carcinoma (Adv. Mater. 41/2024)
Advanced Materials·2024Open Access
Modeling the burden of steatotic liver disease and its subcategories in people living with HIV in Germany
Zeitschrift für Gastroenterologie·2024
Validierung von QuickStroop zur Detektion einer covert hepatischen Enzephalopathie bei Patienten mit Leberzirrhose
Zeitschrift für Gastroenterologie·2024
page 1 of 8Next →

Frequent Co-authors

Peter R. Galle(22), Christian Labenz(21), Jörn M. Schattenberg(20), Detlef Schuppan(18), Maurice Stephan Michel(14), Wolfgang Maximilian Kremer(12), Marcus‐Alexander Wörns(12), Lutz Nuhn(9), Michael Nagel(9), Adrian Klefenz(8), Max Hilscher(8), Simon Johannes Gairing(8), Bernhard Biersack(7), Rainer Schobert(7), Mustafa Diken(7), Sebastian Rosigkeit(7), Matthias Bros(6), Rudolf Zentel(6), Niklas Choteschovsky(5), Kaloian Koynov(5)